Cargando…
Revamping the ever-changing landscape of drug development processes in the midst of COVID-19 pandemic
Oncology is the frontline of drug development. The current pharmaceutical pipeline is disproportional focused on oncology, where about 1/3 of all phases of development is in this therapeutic area. The emphasis brings about substantial breakthroughs and has made positive impact on the quality of life...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081580/ https://www.ncbi.nlm.nih.gov/pubmed/33932595 http://dx.doi.org/10.1016/j.drudis.2021.04.024 |